A randomised double-blind placebo-controlled crossover trial to assess the effect of ZD4522 [rosuvastatin] on the incorporation of trideuterated leucine into lipid subfractions and apolipoproteins in subjects with mild to moderate hyperlipidaemia

Trial Profile

A randomised double-blind placebo-controlled crossover trial to assess the effect of ZD4522 [rosuvastatin] on the incorporation of trideuterated leucine into lipid subfractions and apolipoproteins in subjects with mild to moderate hyperlipidaemia

Not stated
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2006

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top